Condom Designed To Kill HIV Virus

This is a rather strange innovation.

So there has been improvement in science as a condom capable of deactivating 99.9 per cent of HIV, herpes and human papilloma virus cases has been developed. However, the innovation still awaits approval.

Starpharma, an Australian bio-tech firm has developed the antiviral Viva Gel, the active ingredient designed to tackle sexually transmitted infections, in the condom’s lubricant.

The condoms are lubricated with VivaGel, which contains 0.5 per cent astodrimer sodium – a non-
antibiotic, antimicrobial drug designed specifically as a compound against HIV.

The product has now received a receipt of Conformity of Assessment Certification by the Australian Therapeutic Goods Administration, which paves the way for mass production.

With the imminent public release, the gel would help reduce the transmission of HIV and other STIs, while also reducing the risk of pregnancy.

Starpharma partnered with Ansell, which is responsible for around 70 percent of Australia’s condom market to create the new line of Antiviral gel condoms. The recent TGA approval came after the condom was assessed in line with a set of requirements relating to safety and performance.

Peter Carroll, Ansell president, said consumers could expect to see the ‘ground-breaking new sexual health’ product on the shelves soon.

He said, ‘Ansell looks forward to rolling out its marketing and sales campaign to support the launch of LifeStyles Dual Protect over the coming months with the first product expected to be available on shelves soon.’